Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

M. A. Beslagsmed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1% 2.1%   Bankruptcy risk   27.8% 18.8% 8.7% 4.4% 6.3% 9.6% 16.0% 15.7%   Credit score (0-100)   3 8 28 46 37 24 12 12   Credit rating   B B BB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   554 660 0 0 0 0 0 0   Gross profit   357 424 653 688 640 599 0.0 0.0   EBITDA   75.3 13.1 165 94.9 33.0 -26.9 0.0 0.0   EBIT   67.9 3.1 157 93.5 5.8 -60.9 0.0 0.0   Pre-tax profit (PTP)   64.7 -0.3 154.9 83.3 -0.5 -64.8 0.0 0.0   Net earnings   64.7 -0.3 124.2 63.9 -1.4 -57.0 0.0 0.0   Pre-tax profit without non-rec. items   64.7 -0.3 155 83.3 -0.5 -64.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   18.0 15.0 30.9 62.3 144 127 0.0 0.0   Shareholders equity total   1.9 1.6 126 190 188 131 91.3 91.3   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   47.9 46.1 240 384 522 497 91.3 91.3   Net Debt   -13.6 -17.2 -120 -89.7 -104 -130 -91.3 -91.3     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   554 660 0 0 0 0 0 0   Net sales growth   12.1% 19.3% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   357 424 653 688 640 599 0.0 0.0   Gross profit growth   22.2% 18.8% 54.0% 5.3% -6.9% -6.4% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   48 46 240 384 522 497 91 91   Balance sheet change%   28.0% -3.7% 420.4% 60.0% 35.9% -4.8% -81.6% 0.0%   Added value   75.3 13.1 165.3 94.9 7.1 -26.9 0.0 0.0   Added value %   13.6% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   11 -13 7 30 55 -51 -127 0   Net sales trend   1.0 2.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   13.6% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   12.3% 0.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.0% 0.7% 24.0% 13.6% 0.9% -10.2% 0.0% 0.0%   Net Earnings %   11.7% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   13.0% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   11.7% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   91.6% 6.5% 109.5% 30.0% 1.3% -11.9% 0.0% 0.0%   ROI %   7,298.1% 178.7% 233.6% 54.3% 2.7% -34.0% 0.0% 0.0%   ROE %   329.0% -16.8% 195.1% 40.5% -0.7% -35.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   3.9% 3.4% 52.4% 49.4% 36.1% 26.4% 100.0% 100.0%   Relative indebtedness %   8.3% 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   5.9% 4.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -18.0% -131.9% -72.8% -94.5% -313.6% 482.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 1.9 1.7 1.1 0.9 0.0 0.0   Current Ratio   0.4 0.6 1.9 1.7 1.1 1.0 0.0 0.0   Cash and cash equivalent   13.6 17.2 120.4 89.7 103.6 130.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   1.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   77.7 6.7 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   3.3% 4.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -28.0 -18.2 101.7 113.7 39.4 -0.5 0.0 0.0   Net working capital %   -5.0% -2.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0